Skip to main content
Pulsenmore Ltd. logo

Pulsenmore Ltd. — Investor Relations & Filings

Ticker · PULS ISIN · IL0011767006 TA Manufacturing
Open in API
Filings indexed 44 across all filing types
Latest filing 2026-02-02 Regulatory Filings
Country IL Israel
Listing TA PULS

About Pulsenmore Ltd.

https://pulsenmore.com/

Pulsenmore Ltd. is a medical technology company that develops and commercializes home-use ultrasound solutions. Its core product is a portable, self-scan ultrasound device, primarily for prenatal care, that allows patients to perform scans from home. The system is prescribed by a physician and securely connects patients with clinicians for remote guidance, diagnosis, and screening. This digital prenatal care platform is designed to complement routine ultrasound examinations by providing continuity of care. The company's home-use ultrasound solution has received FDA De Novo marketing authorization, pioneering a new approach to remote prenatal monitoring.

Recent filings

Filing Released Lang Actions
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
Regulatory Filings Classification · 1% confidence The document is a short regulatory filing (under 2,000 characters) submitted to the Israel Securities Authority via the MAGNA system. It explicitly states 'Attached hereto is a report on Pulsenmore Announces First Commercial Engagement...' and provides a filename for the attachment. Following the 'Menu vs Meal' rule, this is an announcement of a report publication rather than the report itself, making it a Report Publication Announcement (RPA).
2026-02-02 English
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
Regulatory Filings Classification · 1% confidence The document is a Form 6-K filed with the U.S. Securities and Exchange Commission by Pulsenmore Ltd. A Form 6-K is a report used by foreign private issuers to disclose material information that is required to be made public in their home jurisdiction or provided to security holders. In this specific instance, the document announces a new commercial agreement with Clalit Health Services and includes a press release as an exhibit. Since Form 6-K filings are standard regulatory disclosures for foreign private issuers and do not fit into the more specific categories like 10-K (which is for domestic issuers) or Earnings Releases, it is classified as a Regulatory Filing (RNS).
2026-01-26 English
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
Report Publication Announcement Classification · 1% confidence The document is a short notification from the Israel Securities Authority (MAGNA system) announcing the filing of a Form 6-K. It explicitly states 'Attached hereto is a report on The company's 6-K dated January 26, 2026' and provides a link/reference to the PDF. Per the 'Menu vs Meal' rule, since this is a short announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2026-01-26 English
To Commence Trading on Nasdaq as it expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
Regulatory Filings Classification · 1% confidence The document is a Form 6-K filed with the U.S. Securities and Exchange Commission by Pulsenmore Ltd. A Form 6-K is a report of a foreign private issuer used to disclose material information. In this specific instance, the document serves to announce that the company has commenced trading on the Nasdaq exchange. Since this is a general regulatory filing that provides an update on corporate status (listing on an exchange) and does not fit into more specific categories like 'Earnings Release' or 'Annual Report', it is classified as a Regulatory Filing (RNS).
2026-01-21 English
To Commence Trading on Nasdaq as it expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
Report Publication Announcement Classification · 1% confidence The document is a short regulatory filing (under 2,100 characters) from the Israel Securities Authority (MAGNA system) that explicitly states 'Attached hereto is a report on Pulsenmore To Commence Trading on Nasdaq'. It serves as a notification that a report (Form 6-K) has been published or is attached, rather than being the full report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement.
2026-01-21 English
The English symbol of the Company's shares in TASE systems will be changed as of January 21, 2026
Regulatory Filings Classification · 1% confidence The document is a short notice from the Tel Aviv Stock Exchange (TASE) to its members regarding a change in the ticker symbol for Pulsenmore Ltd. It is a regulatory notification concerning listing details rather than a financial report, management update, or share issuance. As it does not fit into specific categories like 'DLST' (delisting) or 'SHA' (share issue), it falls under the general regulatory announcement category.
2026-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.